ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $5.3M of Alnylam Pharmaceuticals, Inc.
Sold$5,269,457
$105.39Price
50,000Shares
−24%Stake
What ALNY did after the filing
- The stock from Mon, Jul 30 open, $103.97
- −3.5%
- S&P 500, same days
- +2.7%
Measured over 30 trading days, to the Sep 11 close.
Traded Wed, Jul 25. Filed Fri, Jul 27, 4:07 PM ET, after the close. Returns use the Jul 30 open and the Sep 11 close. Not investment advice.